secwatch.observer — SEC 8-K summary
======================================

Issuer:     LIFECORE BIOMEDICAL, INC. DE (LFCR)
CIK:        0001005286
Form:       8-K
Filed at:   2024-07-24T23:59:59+00:00
Accession:  0001005286-24-000093
Event type: other
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Lifecore Biomedical approves FY2025 Annual Incentive Plan with EBITDA-based bonuses
--------------------------------------------------------------------------------

- CEO Paul Josephs target bonus 100% of base salary; CFO John D. Morberg 60%.
- Plan weighted 80% on Adjusted EBITDA and 20% on four business objectives.
- Maximum payout capped at 200% of target; minimum EBITDA threshold required.
- Clawback provision under Compensation Recoupment Policy applies to all payments.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1005286/000100528624000093/0001005286-24-000093-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1005286/000100528624000093/lndc-20240718.htm
  HTML page:      https://secwatch.observer/filing/0001005286-24-000093

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer